Biomarker analysis demonstrates atrial fibrillation recurrence prediction in post-ablation patients, indicating soluble ST2 utility for risk stratification.
The hypothesis of the study was the assumption that the serum levels of soluble ST2 (sST2) and growth differentiation factor (GDF-15) can be predictors of atrial fibrillation (AF) recurrence in long-term period after primary radiofrequency catheter ablation (RFA).
No takes yet. Share an insight, caveat, or question.
Gizatulina et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: